REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
MOLECULAR PERFECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MOLECULAR PERFECTION
ST13
US500000087866829Class
5, 25
Filing
87866829
Registration
6309310
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
03/31/2026
Trademark type
Word
Nice classes
5, 25
Filing date
04/06/2018
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/29/2017
First use in commerce
01/07/2019
Drawing code
4
Owner type
01
Owner location
Irvine, CA, US
Examiner
GLASSER, CARYN
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ashlock, Brett
Representatives
Sophia Sarwar Rutan & Tucker LLP
Technical classification
Nice Classes
Class 5Class 25
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Therapeuticsmedicinal herbsmedicinal herbs in dried or preserved formmedicinal oils and medicinal plants extracts for pharmaceutical purposes for use in the treatment of painmultiple sclerosisneuropatipahtic painspinal cord injurybladder dysfunctionperipheral neuropathycancer painperi-operative painrheumatoid arthritisinflammatory bowel diseaseulcerative colitisCrohn's diseaseAlzheimer's diseaseneurogenic symptomspsychotic disordersdiseases of the central nervous systemstroke and head injurymotion sickness and chemically induced sicknessspasticityoncologycancer symptomspsychiatric illnessesneurodegenerative diseasesmetabolic disordersobesityobesity associated with type II diabetesbulimiaschizophreniaepilepsyDravet syndromeneonatal hypoxiaseizuresalzheimersbone disordersdrugalcohol and nicotine abuseinflammatory disordersprotection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patientsprotection of beta cells in the treatment of diabetic or pre-diabetic patientsmaintenance of insulin levelsimproved control of blood glucose levelstreatment of type I diabetestreatment of type II diabetes; treatment of multiple sclerosisneuropathic painspinal cord injurybladder dysfunctionperipheral neuropathycancer painperi-operative painrheumatoid arthritisinflammatory bowel diseaseneurogenic symptomspsychotic disordersdiseases of the central nervous systemstroke and head injurymotion sickness and neurodegenerative diseasesmetabolic disordersobesityobesity associated with type II diabetesinflammatory disordersherbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes
Class 25
Clothingshirtst-shirtshatsvisors and caps being headwearjacketscoatsskirtsheadbands and
Publications
History of USPTO decisions and trademark events.
51 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/26/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/25/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/05/2021
IUAF
USE AMENDMENT FILED
01/20/2021
EISU
TEAS STATEMENT OF USE RECEIVED
01/20/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/25/2020
EX2G
SOU EXTENSION 2 GRANTED
07/23/2020
EXT2
SOU EXTENSION 2 FILED
07/23/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/23/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/01/2020
EX1G
SOU EXTENSION 1 GRANTED
04/30/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/30/2020
NREV
NOTICE OF REVIVAL - E-MAILED
04/23/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
04/23/2020
PETG
PETITION TO REVIVE-GRANTED
04/23/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
04/23/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/23/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/23/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02/24/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
02/24/2020
EXT1
SOU EXTENSION 1 FILED
01/23/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
11/15/2019
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
11/15/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2019
PUBO
PUBLISHED FOR OPPOSITION
05/28/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/23/2019
ALIE
ASSIGNED TO LIE
04/22/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/09/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/22/2019
GNFR
FINAL REFUSAL E-MAILED
01/22/2019
CNFR
FINAL REFUSAL WRITTEN
01/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/24/2018
GNRT
NON-FINAL ACTION E-MAILED
07/24/2018
CNRT
NON-FINAL ACTION WRITTEN
07/24/2018
DOCK
ASSIGNED TO EXAMINER
07/24/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2018
NWAP
NEW APPLICATION ENTERED
04/10/2018
Continuous trademark protection
Get notified about every new filing that threatens MOLECULAR PERFECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.